Amedisys Inc (AMED) announced their most recent earnings results for the quarter ended in September 2011. The company reported $0.36 per share when analysts were expecting earnings of $0.51. Actual earnings missed estimated earnings by $-0.15 per share. Investors could expect the stock price to fall as earnings were below expectations. Examining previous stock price movement may help to further determine the direction of the share price. Guidance, stock price, and revenue estimates must be considered as well. There are currently 11 analysts covering this firm. Investors can look to their reports for more information. Shares of AMED fell by 0.75% or $-0.075/share to $9.98. In the past year, the shares have traded as low as $9.83 and as high as $38.87. On average, 660514 shares of AMED exchange hands on a given day and today's volume is recorded at 416895.
Radian Group Inc (RDN) reported earnings results for the quarter ended September 2011. They reported actual earnings per share of $-0.17 when they were expecting earnings to be $-0.74 per share. Earnings were 77.03% larger than expected. An upside surprise. Investors might expect the stock price to increase as results were better than expected. Further analysis may need to be done to determine whether the upswing will come to effect. Guidance and revenue estimates must be taken into consideration. A total of 7 analysts are currently covering this company. Shares of RDN traded higher by 7.06% or $0.18/share to $2.73. In the past year, the shares have traded as low as $1.95 and as high as $10.12. On average, 5748320 shares of RDN exchange hands on a given day and today's volume is recorded at 1838134.
Amyris Biotechnologies Inc (AMRS) reported earnings results for the quarter ended September 2011. They reported actual earnings per share of $-0.97 when they were expecting earnings to be $-0.78 per share. Earnings missed estimates by an unexpected -24.36% downside surprise. Investors could expect the stock price to decrease as earnings were worse than expected. Further analysis may need to be conducted to determine whether the downswing will occur. A total of 8 analysts are currently covering this company. Shares of AMRS fell by 9.56% or $-1.85/share to $17.51. In the past year, the shares have traded as low as $17.00 and as high as $33.99. On average, 252271 shares of AMRS exchange hands on a given day and today's volume is recorded at 157373.
Genomic Health Inc (GHDX) reported earnings results for the quarter ended September 2011. The company reported $0.1 per share when analysts were expecting earnings of $0.04. Actual earnings beat estimated earnings by $0.06 per share. Investors could expect the stock price to rise on better than expected results. Further analysis on other trends may need to be completed to determine whether the upswing will be confirmed. Guidance, stock price, and revenue estimates must be considered as well. A total of 15 analysts are currently covering this company. Shares of GHDX traded higher by 14.7% or $3.06/share to $23.88. In the past year, the shares have traded as low as $13.13 and as high as $28.78. On average, 145774 shares of GHDX exchange hands on a given day and today's volume is recorded at 157007.
American Capital, Ltd (ACAS) announced their most recent earnings results for the quarter ended in September 2011. They reported actual earnings per share of $0.19 when they were expecting earnings to be $0.2 per share. Actual earnings missed estimated earnings by $-0.01 per share. Investors could expect the stock price to decrease as earnings were worse than expected. Further analysis may need to be conducted to determine whether the downswing will occur. A total of 10 analysts are currently covering this company. Shares of ACAS fell by 0.27% or $-0.02/share to $7.40. In the past year, the shares have traded as low as $5.65 and as high as $10.85. On average, 5402410 shares of ACAS exchange hands on a given day and today's volume is recorded at 1602229.
